Key facts
- This page summarizes Faith L. Charles's Form 4 filing for CNS Pharmaceuticals, Inc. (CNSP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 May 2026, 09:03.
Faith L. Charles - 18 May 2026 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)
- Reporting relationship
- Director
- Issuer ticker
- CNSP
- Reported as of
- 18 May 2026
- Net transaction value
- +$34,002
- SEC form
- 4
- Accepted by SEC
- 20 May 2026, 09:03:22 UTC
- Prior SEC filing
- 27 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Steve O'Loughlin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Faith L. Charles filed Form 4 for CNS Pharmaceuticals, Inc. (CNSP) on 20 May 2026.
Change
- Previous filing in this sequence was filed on 27 Jan 2026.
- Current net transaction value: +$34,002.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001853985
Primary reporting owner
Charles Faith L.
- Relationship
- Director
- Address
- C/O CNS PHARMACEUTICALS, INC., 100 WEST LOOP SOUTH, SUITE 900, HOUSTON
- Signature
- /s/ Steve O'Loughlin, Attorney-in-Fact
- Signature date
- 20 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNSP
transaction
Common Stock
Purchase
- Transaction value
- $34,002
- Shares
- +7,100
- Change %
- Price
- $4.79
- Shares after
- 7,100
- Date
- 18 May 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Ex 24 - Power of Attorney